SYNERGY PHARMACEUTICALS, INC. 4
4 · SYNERGY PHARMACEUTICALS, INC. · Filed Jun 30, 2017
Insider Transaction Report
Form 4
Spigelman Melvin K
Director
Transactions
- Award
Stock Options
2017-06-28+62,500→ 509,614 totalExercise: $4.50From: 2018-06-28Exp: 2027-06-28→ Common Stock (62,500 underlying) - Award
Stock Options
2017-06-28+12,000→ 509,614 totalExercise: $1.40From: 2017-06-28Exp: 2019-11-20→ Common Stock (12,000 underlying) - Disposition to Issuer
Stock Options
2017-06-28−12,000→ 497,614 totalExercise: $1.40Exp: 2019-11-20→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011.